Zenith Drugs Limited Secures Major Tender for Mupirocin Ointment from Madhya Pradesh Public Health Services Corporation
Zenith Drugs Limited has been awarded a significant tender contract by the Madhya Pradesh Public Health Services Corporation Limited. This substantial order is set to be a meaningful addition to the company's order book, strengthening its standing in the domestic pharmaceutical supply segment.The contract involves the supply of Mupirocin Ointment (2% w/w, 5 gm tube). The total order value has been confirmed at Rs. 45,63,145/-.
Zenith Drugs Limited stated that the contract award was executed in the normal course of business and does not fall under related party transactions.
The key details of the awarded contract are summarized below:
| Detail | Description |
|---|---|
| Awarding Entity | Madhya Pradesh Public Health Services Corporation Limited |
| Product | Mupirocin Ointment (2% w/w, 5 gm tube) |
| Nature of Contract | Supply of Pharmaceutical Product |
| Approximate Quantity | 5,14,447 tubes |
| Total Order Value | Rs. 45,63,145/- |
The company noted that this development is expected to further strengthen its operational performance and positively contribute to shareholder value in the coming periods.
ZENITHDRUG Stock Price Movement
Shares of Zenith Drugs Limited are edging higher to ₹41 as of 3:02 PM today, gaining 3.40% in live trading. The momentum is buoyed by 2,400 shares trading during the session, signaling strong intraday investor interest.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.